Factors associated with DAA virological treatment failure and resistance-associated substitutions description in HIV/HCV coinfected patients

AIM: To describe factors associated with treatment failure and frequency of resistance-associated substitutions (RAS). METHODS: Human immunodeficiency virus (HIV)/hepatitis C virus (HCV) coinfected patients starting a first direct-acting antiviral (DAA) regimen before February 2016 and included in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Salmon, Dominique, Trimoulet, Pascale, Gilbert, Camille, Solas, Caroline, Lafourcade, Eva, Chas, Julie, Piroth, Lionel, Lacombe, Karine, Katlama, Christine, Peytavin, Gilles, Aumaitre, Hugues, Alric, Laurent, Boué, François, Morlat, Philippe, Poizot-Martin, Isabelle, Billaud, Eric, Rosenthal, Eric, Naqvi, Alissa, Miailhes, Patrick, Bani-Sadr, Firouzé, Esterle, Laure, Carrieri, Patrizia, Dabis, François, Sogni, Philippe, Wittkop, Linda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2018
Materias:
Observational Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6280155/
https://www.ncbi.nlm.nih.gov/pubmed/30533186
http://dx.doi.org/10.4254/wjh.v10.i11.856

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6280155/
https://www.ncbi.nlm.nih.gov/pubmed/30533186
http://dx.doi.org/10.4254/wjh.v10.i11.856

Ejemplares similares